Talk:Rochelle Walensky/Archive 1
 | This is an archive of past discussions. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. |
| Archive 1 |
Education, ORCID, etc.
More information could be found [1]; is the officeholder template robust enough for this article? MaynardClark (talk) 15:11, 7 December 2020 (UTC)
Birth date
@MaynardClark: Where did you find her birth date? I didn't see it on the CV. AleatoryPonderings (???) (!!!) 15:50, 7 December 2020 (UTC)
- The currently published Harvard CV does not include it. IMO we ought to take it off. NTOE: Various Internet sources (other than the current CV) show 3 different dates (9/16/69), 4/5/69, 5/4/69). Calculating December 2020 minus 51 years gives a pretty solid 1969. MaynardClark (talk) 16:22, 7 December 2020 (UTC)
- MaynardClark, Gotcha. It'll presumably emerge in a RS at some point, and we can add it then. AleatoryPonderings (???) (!!!) 16:24, 7 December 2020 (UTC)
Suggested content for coverage of her research
Some statements to consider, summarizing her work:
- She led a highly-cited study that showed, as of 2006, that HIV treatment had saved over 3 million life-years in the USA alone.[1] (cited over 600 times)
- She studies the cost-effectiveness of interventions along the continuum of HIV care from screening to prevention to screening and treatment, in the USA and other countries.[2][3][4][5][6] (the Paltiel NEJM 2005 paper has been cited over 600 times, the Paltiel Ann Intern Med 2006 paper over 250 times, the Paltiel Clin Infect Dis 2009 paper over 250 times)
I would edit directly but I know her personally. — soupvector (talk) 12:42, 7 December 2020 (UTC)
- I'll also note that much of what's in the "Research" section currently is, IMHO, not research. — soupvector (talk) 17:45, 7 December 2020 (UTC)
- Soupvector, I changed it to "COVID-19". Afaik, we'd need secondary commentary on these papers to include them in the article (would be OR to summarize them based only on the research itself). I've seen some news coverage about a few of her papers, and will try to add that at some point. AleatoryPonderings (???) (!!!) 17:51, 7 December 2020 (UTC)
- You're right, of course. I'll try to find a few examples, but here's a start:
- In a contemporaneous commentary, Sten Vermund (is that really a redlink? He's Dean of Yale's School of Public Health) discusses the impact of ref #1.[7]
- In this 2010 review, Walensky's work is prominently cited (see refs 108, 142, and 143).[8]
- If you search Google Books for Dr. Walensky's name, you'll find many reference books citing her work.
- I'll try to find some more when I get a chance, but I hope others might chip in, too. — soupvector (talk) 06:28, 8 December 2020 (UTC)
- You're right, of course. I'll try to find a few examples, but here's a start:
- Soupvector, I changed it to "COVID-19". Afaik, we'd need secondary commentary on these papers to include them in the article (would be OR to summarize them based only on the research itself). I've seen some news coverage about a few of her papers, and will try to add that at some point. AleatoryPonderings (???) (!!!) 17:51, 7 December 2020 (UTC)
References
- ^ Walensky, Rochelle P.; Paltiel, A. David; Losina, Elena; Mercincavage, Lauren M.; Schackman, Bruce R.; Sax, Paul E.; Weinstein, Milton C.; Freedberg, Kenneth A. (July 2006). "The Survival Benefits of AIDS Treatment in the United States". The Journal of Infectious Diseases. 194 (1): 11–19. doi:10.1086/505147. ISSN 0022-1899.
- ^ Paltiel, A. David; Walensky, Rochelle P.; Schackman, Bruce R.; Seage, George R.; Mercincavage, Lauren M.; Weinstein, Milton C.; Freedberg, Kenneth A. (2006-12-05). "Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs". Annals of Internal Medicine. 145 (11): 797–806. doi:10.7326/0003-4819-145-11-200612050-00004. ISSN 1539-3704. PMID 17146064.
- ^ Paltiel, A. David; Freedberg, Kenneth A.; Scott, Callie A.; Schackman, Bruce R.; Losina, Elena; Wang, Bingxia; Seage, George R.; Sloan, Caroline E.; Sax, Paul E.; Walensky, Rochelle P. (2009-03-15). "HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 48 (6): 806–815. doi:10.1086/597095. ISSN 1537-6591. PMC 2876329. PMID 19193111.
- ^ Paltiel, A. David; Weinstein, Milton C.; Kimmel, April D.; Seage, George R.; Losina, Elena; Zhang, Hong; Freedberg, Kenneth A.; Walensky, Rochelle P. (2005-02-10). "Expanded screening for HIV in the United States--an analysis of cost-effectiveness". The New England Journal of Medicine. 352 (6): 586–595. doi:10.1056/NEJMsa042088. ISSN 1533-4406. PMID 15703423.
- ^ Neilan, Anne M.; Bulteel, Alexander J. B.; Hosek, Sybil G.; Foote, Julia H. A.; Freedberg, Kenneth A.; Landovitz, Raphael J.; Walensky, Rochelle P.; Resch, Stephen C.; Kazemian, Pooyan; Paltiel, A. David; Weinstein, Milton C. (2020-07-30). "Cost-effectiveness of frequent HIV screening among high-risk young men who have sex with men in the United States". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. doi:10.1093/cid/ciaa1061. ISSN 1537-6591. PMID 32730625.
- ^ Ouattara, Eric N.; MacLean, Rachel L.; Danel, Christine; Borre, Ethan D.; Gabillard, Delphine; Huang, Mingshu; Moh, Raoul; Paltiel, A. David; Eholié, Serge P.; Walensky, Rochelle P.; Anglaret, Xavier (2019). "Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis". PloS One. 14 (6): e0219068. doi:10.1371/journal.pone.0219068. ISSN 1932-6203. PMC 6597104. PMID 31247009.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ Vermund, Sten H. (2006-07-01). "Millions of life-years saved with potent antiretroviral drugs in the United States: a celebration, with challenges". The Journal of Infectious Diseases. 194 (1): 1–5. doi:10.1086/505154. ISSN 0022-1899. PMID 16741874.
- ^ Broder, Samuel (January 2010). "The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic". Antiviral Research. 85 (1): 1–18. doi:10.1016/j.antiviral.2009.10.002. ISSN 1872-9096. PMC 2815149. PMID 20018391.
Commons files used on this page or its Wikidata item have been nominated for deletion
The following Wikimedia Commons files used on this page or its Wikidata item have been nominated for deletion:
- Mask promotional video from Biden-Harris health care leaders in 2020.ogv (discussion)
- Rochelle Walensky screenshot from COVID education video in 2020.png (discussion)
Participate in the deletion discussions at the nomination pages linked above. —Community Tech bot (talk) 08:07, 15 December 2020 (UTC)
Rochelle Walensky’s nationality
Why is she listed as Israeli Jewish when she is American? She was born in the United States.
Does Wikipedia normally describe people as Christian American? No 67.188.191.164 (talk) 11:19, 9 December 2021 (UTC)
I fixed it. Anti-Semitic bullshit. Chicagoperson (talk) 22:59, 10 December 2021 (UTC)
Physician-scientist
Physician-scientist is defined in the bio as one with medical degree and Ph.D so why is that applied to this person who doesn't have a Ph.D. In her husband's bio it is consistently applied. Drop the title for this person, change the definition, or explain the deviation — Preceding unsigned comment added by 2600:1700:E1F0:6560:31A2:8533:BCEB:ECB2 (talk) 16:25, 8 January 2022 (UTC)
Heritage
What is the national origin of Walensky's Jewish heritage? Is she of Sephardic heritage? 173.88.246.138 (talk) 00:26, 7 March 2022 (UTC)